Publikasi Scopus 2024 per tanggal 31 Juli 2024 (607 artikel)

Habiburrahman M.; Sutopo S.; Sarkowi W.K.
Habiburrahman, Muhammad (57204537114); Sutopo, Stefanus (57749107800); Sarkowi, Widya Khairunnisa (58485303400)
57204537114; 57749107800; 58485303400
Plausible use of citicoline as an adjuvant in central nervous system infections: A case report and review of the literature
2024
World Academy of Sciences Journal
6
4
e39
0
Faculty of Medicine, Universitas Indonesia, Central Jakarta, DKI Jakarta, 10430, Indonesia; Dr. Cipto Mangunkusumo Hospital, Central Jakarta, DKI Jakarta, 10430, Indonesia; Tebet Subdistrict Public Hospital, South Jakarta, DKI Jakarta, 12810, Indonesia; Faculty of Medicine, Imperial College London, London, SW7 2AZ, United Kingdom; School of Infection and Immunity, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, United Kingdom; Faculty of Medicine, IPB University, West Java, Bogor, 16680, Indonesia; Faculty of Medicine, Universitas Indonesia, Salemba Raya Street No. 6, Senen Subdistrict, Central Jakarta, DKI Jakarta, 10430, Indonesia
Habiburrahman M., Faculty of Medicine, Universitas Indonesia, Central Jakarta, DKI Jakarta, 10430, Indonesia, Dr. Cipto Mangunkusumo Hospital, Central Jakarta, DKI Jakarta, 10430, Indonesia, Tebet Subdistrict Public Hospital, South Jakarta, DKI Jakarta, 12810, Indonesia, Faculty of Medicine, Imperial College London, London, SW7 2AZ, United Kingdom, Faculty of Medicine, Universitas Indonesia, Salemba Raya Street No. 6, Senen Subdistrict, Central Jakarta, DKI Jakarta, 10430, Indonesia; Sutopo S., Faculty of Medicine, Universitas Indonesia, Central Jakarta, DKI Jakarta, 10430, Indonesia, Dr. Cipto Mangunkusumo Hospital, Central Jakarta, DKI Jakarta, 10430, Indonesia, School of Infection and Immunity, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, United Kingdom, Faculty of Medicine, Universitas Indonesia, Salemba Raya Street No. 6, Senen Subdistrict, Central Jakarta, DKI Jakarta, 10430, Indonesia; Sarkowi W.K., Faculty of Medicine, Imperial College London, London, SW7 2AZ, United Kingdom, Faculty of Medicine, IPB University, West Java, Bogor, 16680, Indonesia
Citicoline has been widely used for the treatment of neurological conditions of the central nervous system (CNS), and exhibit potential for infection management, providing anti-inflammatory, antiviral, antioxidant and neuroprotective properties. The present study describes the case of a 50-year-old male patient co-infected with suspected tuberculosis and COVID-19 affecting the CNS who was treated with citicoline. The study aimed to raise clinical questions and initiate a comprehensive literature review. It also aimed to explore the plausible benefits of the use of citicoline in restoring consciousness and alleviating neurological symptoms in CNS infections. In the literature review, eight studies, including two quasi-experimental studies, five literature reviews, and one case report were found to be relevant to the case of the patient described herein, and they suggested that citicoline demonstrated partial protection against cerebral malaria, prevented encephalitis sequelae when immediately administered, and inhibited coronavirus replication. Additionally, six studies reported the potential of citicoline in the treatment of neurological conditions, such as ethambutol-induced optic neuropathy, stroke, head trauma and CNS infections caused by cerebral malaria and COVID-19, compared to standard therapy. Citicoline shows promise as an adjuvant therapy for neurological complications associated with CNS infections. © 2024 Spandidos Publications. All rights reserved.
adjuvant therapy; central nervous system infections; citicoline; evidence-based case report; neurological disorders
Spandidos Publications
26322900
Article
Q3
317
14612